Immunovaccine Begins Patient Recruitment for Phase 1 Trial of DPX-0907 Cancer Vaccine

Immunovaccine Begins Patient Recruitment for Phase 1 Trial of DPX-0907 Cancer Vaccine
HALIFAX, NOVA SCOTIA– – Immunovaccine Inc. today announced that it has started screening patients for its Phase 1 clinical trial, investigating the company’s therapeutic cancer vaccine, DPX-0907, as a treatment for patients with advanced stage breast, ovarian and prostate cancer.

Read more on CCNMatthews via Yahoo! Finance

Immunovaccine Begins Patient Recruitment for Phase 1 Trial of DPX-0907 Cancer Vaccine
HALIFAX, NOVA SCOTIA–(Marketwire – 03/29/10) – Immunovaccine Inc. (TSX-V: IMV – News ) today announced that it has started screening patients for its Phase 1 clinical trial, investigating the company’s therapeutic cancer vaccine, DPX-0907, as a treatment for patients with advanced stage breast, ovarian and prostate cancer. The primary goal of the trial is to establish the safety of the vaccine …

Read more on Marketwire via Yahoo! Finance

Related prostate health articles:

None Found

---